ATE290073T1 - Expressionsvektoren die 'hot spots'für eine verstärkte rekombinante proteinexpression in transfizierten zellen enthalten - Google Patents

Expressionsvektoren die 'hot spots'für eine verstärkte rekombinante proteinexpression in transfizierten zellen enthalten

Info

Publication number
ATE290073T1
ATE290073T1 AT99948139T AT99948139T ATE290073T1 AT E290073 T1 ATE290073 T1 AT E290073T1 AT 99948139 T AT99948139 T AT 99948139T AT 99948139 T AT99948139 T AT 99948139T AT E290073 T1 ATE290073 T1 AT E290073T1
Authority
AT
Austria
Prior art keywords
contain
expression
recombinant protein
transfected cells
hot spots
Prior art date
Application number
AT99948139T
Other languages
English (en)
Inventor
Kanakaraju Koduri
John T Miller
Pallaiah Thammana
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE290073T1 publication Critical patent/ATE290073T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99948139T 1998-09-22 1999-09-07 Expressionsvektoren die 'hot spots'für eine verstärkte rekombinante proteinexpression in transfizierten zellen enthalten ATE290073T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10129298P 1998-09-22 1998-09-22
PCT/US1999/020467 WO2000017337A1 (en) 1998-09-22 1999-09-07 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells

Publications (1)

Publication Number Publication Date
ATE290073T1 true ATE290073T1 (de) 2005-03-15

Family

ID=22283889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99948139T ATE290073T1 (de) 1998-09-22 1999-09-07 Expressionsvektoren die 'hot spots'für eine verstärkte rekombinante proteinexpression in transfizierten zellen enthalten

Country Status (10)

Country Link
US (1) US6521419B1 (de)
EP (1) EP1115852B1 (de)
JP (1) JP4480893B2 (de)
AT (1) ATE290073T1 (de)
AU (1) AU762274B2 (de)
CA (1) CA2344699A1 (de)
DE (1) DE69923983T2 (de)
ES (1) ES2237943T3 (de)
IL (1) IL141878A0 (de)
WO (1) WO2000017337A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800457B2 (en) * 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
EP1600510B1 (de) * 2001-07-04 2007-03-28 Chromagenics B.V. DNS-Sequenzen mit anti-repressor Aktivität
CA2385110A1 (en) * 2002-05-06 2003-11-06 University Of British Columbia Co-expression system for large functional proteins
DK1513937T3 (da) * 2002-06-14 2011-05-16 Chromagenics Bv Fremgangsmåde til den samtidige produktion af multiple proteiner; vektorer og celler til anvendelse derved
AU2003243059A1 (en) * 2002-06-14 2003-12-31 Chromagenics B.V. Use of repression blocking sequences in methods for enhancing gene expression
ES2373549T3 (es) * 2002-12-18 2012-02-06 Chromagenics B.V. Método para mejorar la producción de proteínas.
AU2003290453A1 (en) * 2002-12-20 2004-07-14 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
US8999667B2 (en) * 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
MX2007004595A (es) * 2004-11-08 2007-08-15 Chromagenics Bv Seleccion de celulas hospederas que expresan proteinas en altas concentraciones.
SI1809750T1 (sl) 2004-11-08 2012-08-31 Chromagenics Bv Izbira gostiteljskih celic, ki imajo visok nivo izraĹľanja proteina
US8039230B2 (en) * 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
AR058568A1 (es) 2005-12-20 2008-02-13 Bristol Myers Squibb Co Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
KR101398713B1 (ko) 2005-12-20 2014-06-12 브리스톨-마이어스 스큅 컴퍼니 조성물 및 조성물의 제조 방법
CA2693972C (en) 2007-07-19 2019-01-15 Medical Components, Inc. Venous access port assembly with x-ray discernable indicia
WO2009058564A2 (en) * 2007-11-01 2009-05-07 Maxygen, Inc. Immunosuppressive polypeptides and nucleic acids
JP4568378B2 (ja) * 2008-08-29 2010-10-27 東洋紡績株式会社 遺伝子発現安定化エレメント
CN103305504B (zh) * 2012-03-14 2016-08-10 江苏吉锐生物技术有限公司 在仓鼠细胞中定点重组的组合物和方法
MX2017005306A (es) 2014-10-23 2018-01-09 Regeneron Pharma Novedosos sitios de integracion en celulas cho y usos de estos.
US11560549B2 (en) 2017-08-11 2023-01-24 Boehringer Ingelheim International Gmbh Integration sites in CHO cells
MX2021011903A (es) * 2019-04-02 2021-10-26 Chugai Pharmaceutical Co Ltd Método para introducir un gen extraño específico del objetivo.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844095A (en) 1991-06-27 1998-12-01 Bristol-Myers Squibb Company CTLA4 Ig fusion proteins
KR100238712B1 (ko) 1991-06-27 2000-01-15 스티븐 비. 데이비스 씨티엘에이4 수용체,그를 함유한 연합단백질 및 그의 용도
US5747034A (en) 1992-07-09 1998-05-05 Chiron Corporation Methods and materials for the induction of T cell anergy
US5773253A (en) 1993-01-22 1998-06-30 Bristol-Myers Squibb Company MYPPPY variants of CTL A4 and uses thereof
CA2177959C (en) 1993-12-23 2007-02-13 Gregory Franklin Hollis Homologous recombination antibody expression system for murine cells
CA2241174C (en) 1996-01-11 2006-09-12 Immunex Corporation Expression augmenting sequence elements (ease) for eukaryotic expression systems

Also Published As

Publication number Publication date
DE69923983T2 (de) 2006-04-06
CA2344699A1 (en) 2000-03-30
JP2002526071A (ja) 2002-08-20
EP1115852A1 (de) 2001-07-18
DE69923983D1 (de) 2005-04-07
ES2237943T3 (es) 2005-08-01
US6521419B1 (en) 2003-02-18
IL141878A0 (en) 2002-03-10
AU762274B2 (en) 2003-06-19
JP4480893B2 (ja) 2010-06-16
AU6137599A (en) 2000-04-10
EP1115852B1 (de) 2005-03-02
EP1115852A4 (de) 2002-09-25
WO2000017337A1 (en) 2000-03-30

Similar Documents

Publication Publication Date Title
ATE290073T1 (de) Expressionsvektoren die 'hot spots'für eine verstärkte rekombinante proteinexpression in transfizierten zellen enthalten
DE69936104D1 (de) Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten
Boer et al. Polymorphisms in the coding and noncoding regions of murine Pgk-1 alleles
Virgin et al. The gene for the beta subunit of bovine luteinizing hormone encodes a gonadotropin mRNA with an unusually short 5'-untranslated region.
BR9804896A (pt) Dna isolado e purificado, célula hospedeira, vetor, polinucleotídeo quimérico, plasmídeo e processo para aumentar a transcrição de um gene de interesse em uma célula hospedeira
DE69535703D1 (de) Aav-vermittelte überbringung von dna in zellen des nervensystems
EP0804609A4 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
FI962268A0 (fi) Homologinen, rekombinanttinen vasta-aineilmentämisjärjestelmä rottien tai hiirien soluille
CA2311643A1 (en) Compositions and methods for inducing gene expression
CY1109367T1 (el) Συνθεσεις και μεθοδοι για ενισχυση της παροχης θεραπευτικων παραγοντων σε κυτταρα
EP1011717A4 (de) Arginin deiminase aus mycoplasma arthirtidis und sie enthaltende polymerkonjugate
ATE284969T1 (de) Rekombinante adenovirale vektoren, die eine spleissequenz enthalten
ATE384787T1 (de) Tripeptidyl-aminopeptidase
BR0316510A (pt) Vetor de expressão, processo para a preparação de produtos gênicos heterólogos e processo de seleção para células recombinantes de alta produção
ATE288488T1 (de) Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen
ZA200404424B (en) Genes encoding for genetic stability, gene expression and folding proteins.
DE69940267D1 (de) Wirtszellen, die rekombinantes humanes erythropoietin exprimieren
WO1998025957A3 (en) Human prt1-like subunit protein (hprt1) and human eif4g-like protein (p97) genes
EP0924295A3 (de) DNS kodierend für Neospora Dihydrofolatreductase-Thymidylate Synthase
EP1571215A3 (de) Gene und Proteine von vertebraten Telomerasen, und deren Verwendungen
Chan et al. The primary structure of rat ribosomal protein S25
Vosberg et al. REGULATION OF THE HUMAN B-MYOSIN HEAVY CHAIN GENE AND AN APPROACH TO A FUNCTIONAL ANALYSIS OF RECOMBINANT PROTEIN SUBREGIONS OF THE B-CHAIN
GB2409680A (en) Methods for controlling proliferation of cells
BR9810643A (pt) Genes e proteìnas de telomerase de vertebrado, eutilização dos mesmos
ATE283357T1 (de) Tumor-suppressorgen del-27 und das dadurch kodierte protein, verfahren zu deren herstellung und nutzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1115852

Country of ref document: EP